XERS - Xeris Biopharma Holdings Inc
IEX Last Trade
2.805
0.005 0.178%
Share volume: 781,944
Last Updated: Fri 30 Aug 2024 09:59:47 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$2.80
0.01
0.18%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-10 | 2022-11-09 | 2023-03-08 | 2023-05-09 | 2023-08-08 | 2023-11-09 | 2024-03-06 | 2024-05-09 | |
| Total revenue | 25.306 M | 29.725 M | 33.144 M | 33.196 M | 38.008 M | 48.320 M | 44.390 M | 40.638 M | |
| Cost of revenue | 4.810 M | 5.260 M | 6.291 M | 5.319 M | 7.555 M | 8.201 M | 7.570 M | 5.971 M | |
| Gross profit | 20.496 M | 24.465 M | 26.853 M | 27.877 M | 30.453 M | 40.119 M | 36.820 M | 34.667 M | |
| 19.36% | 9.76% | 3.81% | 9.24% | 31.74% | -8.22% | -5.85% | |||
| Operating expenses | 36.702 M | 40.534 M | 39.312 M | 38.443 M | 43.722 M | 42.321 M | 43.950 M | 46.201 M | |
| Selling general and admin | 32.984 M | 34.491 M | 34.357 M | 33.605 M | 37.635 M | 37.287 M | 37.568 M | 38.380 M | |
| Research and development | 3.718 M | 6.043 M | 4.955 M | 4.838 M | 6.087 M | 5.034 M | 6.382 M | 7.821 M | |
| Total expenses | 44.222 M | 48.505 M | 48.314 M | 46.473 M | 53.987 M | 53.233 M | 54.231 M | 54.883 M | |
| 9.69% | -0.39% | -3.81% | 16.17% | -1.40% | 1.87% | 1.20% | |||
| Operating income | -18.916 M | -18.780 M | -15.170 M | -13.277 M | -15.979 M | -4.913 M | -9.841 M | -14.245 M | |
| Ebit | -18.916 M | -18.780 M | -15.170 M | -13.277 M | -15.979 M | -4.913 M | -9.841 M | -14.245 M | |
| Pretax income | -26.524 M | -22.170 M | -13.268 M | -16.834 M | -20.517 M | -12.527 M | -13.626 M | -18.673 M | |
| -16.42% | -40.15% | 26.88% | 21.88% | -38.94% | 8.77% | 37.04% | |||
| Income tax | -339.000 K | -339.000 K | -338.000 K | 0.000 | -675.000 K | -338.000 K | -236.000 K | 307.000 K | |
| Net income basic | -26.185 M | -21.831 M | -12.930 M | -16.834 M | -19.842 M | -12.189 M | -13.390 M | -18.980 M | |
| 16.63% | 40.77% | -30.19% | -17.87% | 38.57% | -9.85% | -41.75% | |||
| Net income | -26.185 M | -21.831 M | -12.930 M | -16.834 M | -19.842 M | -12.189 M | -13.390 M | -18.980 M | |
| 16.63% | 40.77% | -30.19% | -17.87% | 38.57% | -9.85% | -41.75% |